Discontinued — last reported Q4 '25
Johnson & Johnson Net Income decreased by 7.0% to $5.15B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 91.2%, from $2.69B to $5.15B. Over 3 years (FY 2021 to FY 2024), Net Income shows a downward trend with a -4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved profitability and potential for higher dividends or reinvestment, while a decrease may indicate rising costs or falling sales.
The total profit of the company after all expenses, taxes, and interest have been deducted from total revenue. In the ca...
Peers like Alphabet or Apple use this as the primary benchmark for bottom-line performance and earnings per share (EPS) calculations.
cf_net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.20B | $6.28B | $3.67B | $3.52B | $5.15B | $4.81B | $4.46B | $26.03B | -$68.00M | $5.14B | $4.05B | $3.26B | $4.69B | $2.69B | $3.43B | $11.00B | $5.54B | $5.15B |
| QoQ Change | — | +1.3% | -41.6% | -4.0% | +46.3% | -6.5% | -7.4% | +483.8% | -100.3% | >999% | -21.3% | -19.6% | +44.0% | -42.5% | +27.4% | +220.6% | -49.7% | -7.0% |
| YoY Change | — | — | — | — | -16.9% | -23.3% | +21.6% | +639.4% | -101.3% | +6.9% | -9.2% | -87.5% | >999% | -47.6% | -15.3% | +237.9% | +18.2% | +91.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.